Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 336-341

  Feng, Xiao Li ^a   Li, Ling ^a   Gao, Yan Ning ^a   Zhang, Jian Jun ^a   Xiao, Ting ^a   Ying, Jian Ming ^a   Gao, Ji Dong ^a   Sun, Yun Tian ^a   Cheng, Shu Jun ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

C erbB 2; Immunohistochemistry; Lung cancer; p16; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; TISSUE MICROARRAY;

EID: 85027957722     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-010-9452-0     Document Type: Article

References (24)

1. L Li F Lu S Zhang 1997 Analyses of variation trend and short-term detection of Chinese malignant tumor mortality during twenty years Zhonghua Zhong Liu Za Zhi 19 3 9 10743044 1:STN:280:DC%2BD3c3gslCntQ%3D%3D
2. G Ferretti A Felici P Papaldo A Fabi F Cognetti 2007 HER2/neu role in breast cancer: from a prognostic foe to a predictive friend Curr Opin Obstet Gynecol 19 56 62 17218853 10.1097/GCO.0b013e328012980a (Pubitemid 46095874)
3. J Liang KR Mittal JJ Wei H Yee L Chiriboga P Shukla 2007 Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions Int J Gynecol Pathol 26 71 75 17197900 10.1097/01.pgp.0000225851.97739.9f (Pubitemid 46036962)
4. Travis WD, Colby TV, Corrin B, et al. World health organization international histological classification of tumours: histological typing of lung and pleural tumours. 3rd ed. Berlin, Germany: Springer; 1999.
5. SPSS Inc. SPSS Base10.0 Applications Guide. Chicago, IL: SPSS Inc.; 1999.
6. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1711 1717
7. FR Hirsch CJ Langer 2004 The role of HER2/neu expression and trastuzumab in non-small cell lung cancer Semin Oncol 31 75 82 14981584 10.1053/j. seminoncol.2003.12.018 1:CAS:528:DC%2BD2cXisFelsbY%3D (Pubitemid 38241024)
8. K Ugocsai L Mándoky L Tiszlavicz J Molnár 2005 Investigation of HER2 overexpression in non-small cell lung cancer Anticancer Res 25 3061 3066 16080566 1:CAS:528:DC%2BD2MXpt1Wrtbo%3D (Pubitemid 41044701)
9. Z Calikusu Y Yildirim Z Akcali H Sakalli N Bal O Ozyilkan 2009 Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients Asian Pac J Cancer Prev 10 479 482 19640195
10. J Seidenfeld DJ Samsom BM Rothenberg CJ Bonnell KM Ziegler 2008 Aronson N HER2 testing to manage patients with breast cancer or other solid tumors Evid Rep Technol Assess (Full Rep) 172 1 362
11. C Papila H Uzun H Balci H Zerdali C Sezgin G Can H Yanardag 2009 Clinical significance and prognostic value of serum sHER-2/neu levels in patients with solid tumors Med Oncol 26 151 156 18855148 10.1007/s12032-008-9098-3 1:CAS:528:DC%2BD1MXmtVKit7w%3D
12. XL Feng XB Zhang YX Wan JH Ma YT Sun 2002 Expressions of C-erbB-2 protein in tissues and cell lines of renal cell carcinoma Chin J Pathol 31 158 159
13. N Reinmuth B Brandt WP Kunze K Junker M Thomas R Achatzy HH Scheld M Semik 2000 Ploidy, expression of erbB1, erbB-2, P53 and amplification of erbB1, erbB2, and erbB3 in non-small cell lung cancer Eur Respir J 16 991 996 11153605 10.1183/09031936.00.16599100 1:CAS:528:DC%2BD3MXktVymtA%3D%3D (Pubitemid 32049392)
14. CM Cheng K Tsuneyama K Matsui H Takahashi S Ishizawa Y Takano 2005 Cytoplasmic expression of c-erbB2 in non-small cell lung cancers Virchows Arch 446 596 603 15902485 10.1007/s00428-005-1258-7 1:CAS:528:DC%2BD2MXltlagsLY%3D (Pubitemid 40922264)
15. KA Wikenheiser-Brokamp 2006 Retinoblastoma regulatory pathway in lung cancer Curr Mol Med 6 783 793 17100603 1:CAS:528:DC%2BD28XhtFWgtrzJ
16. V Esposito A Baldi A De Luca G Tonini B Vincenzi D Santini P Persichetti A Mancini G Citro F Baldi AM Groeger M Caputi 2005 Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer J Clin Pathol 58 734 739 15976342 10.1136/jcp.2004.023531 1:CAS:528: DC%2BD2MXntV2lu78%3D (Pubitemid 40956829)
17. J Sanz-Ortega F Roig MM Al-Mousa MC Saez A Muñoz J Sanz-Esponera L Callol 2007 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer Histol Histopathol 22 541 545 17330809 1:CAS:528:DC%2BD2sXnsFKjsbY%3D (Pubitemid 46655477)
18. WL Ho JW Chang RC Tseng JT Chen CY Chen YS Jou YC Wang 2002 Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer Cancer Detect Prev 26 343 349 12518864 10.1016/S0361-090X(02)00088-0 1:CAS:528:DC%2BD3sXnt12hsw%3D%3D (Pubitemid 36035379)
19. S Nakata K Sugio H Uramoto T Oyama T Hanagiri M Morita K Yasumoto 2006 The methylation status and protein expression of CDH1, p16 (INK4A), and fragile histidine triad in non-small cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance Cancer 106 2190 2199 16598757 10.1002/cncr.21870 1:CAS:528:DC%2BD28XkvFOnt7g%3D (Pubitemid 43673241)
20. S Singhal A Vachani D Antin-Ozerkis LR Kaiser SM Albelda 2005 Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review Clin Cancer Res 11 3974 3986 15930332 10.1158/1078-0432.CCR-04-2661 1:CAS:528:DC%2BD2MXks1Glu7c%3D (Pubitemid 40791561)
21. I Abdulkader L Sánchez J Cameselle-Teijeiro F Gude JE Chávez R López-López J Forteza M Fraga 2005 Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study Oncol Rep 14 1527 1531 16273250 1:CAS:528: DC%2BD2MXhtlGns77E
22. K Evangelou J Bramis I Peros P Zacharatos D Dasiou-Plakida N Kalogeropoulos PJ Asimacopoulos C Kittas E Marinos VG Gorgoulis 2004 Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas Biotech Histochem 79 5 10 15223748 10.1080/10520290310001659466 1:CAS:528: DC%2BD2cXkvFWlurw%3D (Pubitemid 38997099)
23. K Milde-Langosch AM Bamberger G Rieck B Kelp T Loning 2001 Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype Breast Cancer Res Treat 67 61 70 11518467 10.1023/A:1010623308275 1:CAS:528:DC%2BD3MXms1SiurY%3D (Pubitemid 32703389)
24. P Zhao YC Hu IC Talbot 2003 Expressing patterns of p16 and CDk4 correlated to prognosis in colorectal carcinoma World J Gastroenterol 9 2202 2206 14562378 1:CAS:528:DC%2BD3sXpsVOjtrw%3D (Pubitemid 37321445)